Drug Patent Expirations in February 2010
Drug Patent Expirations in February 2010
*Drugs may be covered by multiple patents
Tradename
Applicant
Generic Name
Patent Number
Patent Expiration
ZAGAM
Mylan
sparfloxacin
4,795,751
Feb 4, 2010
TEVETEN
Abbott
eprosartan mesylate
5,185,351
Feb 9, 2010
MYOVIEW
Ge Healthcare
technetium tc-99m tetrofosmin kit
5,045,302
Feb 9, 2010
TEVETEN HCT
Abbott
eprosartan mesylate; hydrochlorothiazide
5,185,351
Feb 9, 2010
HYZAAR
Merck
hydrochlorothiazide; losartan potassium
5,138,069*PED
Feb 11, 2010
COZAAR
Merck
losartan potassium
5,138,069*PED
Feb 11, 2010
EXUBERA
Pfizer
insulin recombinant human
RE37872
Feb 12, 2010
EXUBERA
Pfizer
insulin recombinant human
RE38385
Feb 12, 2010
MEPRON
Glaxosmithkline
atovaquone
4,981,874*PED
Feb 15, 2010
NITRO-DUR
Key Pharms
nitroglycerin
5,186,938
Feb 16, 2010
SANDIMMUNE
Novartis
cyclosporine
7,511,014
Feb 16, 2010
ALDARA
Graceway
imiquimod
4,689,338*PED
Feb 25, [...]


02. Feb, 2010 





































